INDOOR AND BUILT ENVIRONMENT-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1091886, encodeId=5787109188664, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091885, encodeId=6cea1091885c1, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861247, encodeId=119b86124e5d, content=审稿速度:2.0 经验分享：审核意见挺中肯的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Sun May 31 19:55:36 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854808, encodeId=47e485480833, content=审稿速度:3.0 经验分享：搜寻了yu chuck，好像此人只在他自己主编的这个期刊上发论文，而且基本上都不是一作。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Nov 07 10:56:55 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854807, encodeId=87fe85480e80, content=审稿速度:3.0 经验分享：yu chuck喜欢玩猫捉老鼠.先给你小修，然后再给你大修，最后给你拒绝。虽然你每次都认真改了，而且改的非常到位了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Nov 07 10:53:20 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853069, encodeId=ecd385306948, content=审稿速度:12.0 经验分享：yu chuck业内人品真不好说 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Fri Aug 09 10:00:37 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852280, encodeId=72f28522800a, content=24-feb-2019_submit 11-apr-2019_major revision 11-may-2019_a revision has been submitted (ibe-19-0060.r1) 09-jun-2019_minor revision_please provide institutional email address, not personal email address... 19-jun-2019_a revision has been submitted (ibe-19-0060.r2) 28-jun-2019_reject_at the moment, it seems the paper is written by a student who is not really an expert on indoor air quality... adm: yu, chuck , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893e5414041, createdName=ms8120435325541008, createdTime=Fri Jun 28 17:16:20 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851469, encodeId=b42d85146955, content=审稿速度:6.0 经验分享：审稿速度一般，4个月给初审结果，2个月以后给了小修结果，两周以后竟然在一个审稿人建议直接发表，另一个审稿人建议题目上添加“nunmerical study on”的情况下，给拒掉了，给拒掉了，给拒掉了......这是什么情况，让人太无语......除非必要，建议慎投. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Mon May 20 08:55:57 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847898, encodeId=80e484e898f2, content=期刊一审速度较快，大约20几天。三个审稿人，都给了比较专业的意见。主编认真负责，也提了一些中肯的修改意见。编辑也很细心，给予了文章的很多细节方面的修改。从投到接收大约一个半月左右，效率挺快的。总之，该期刊值得更多人的关注与投稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sat Oct 27 20:40:04 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847897, encodeId=c70a84e89730, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：该杂志审稿速度比较快，一审回复意见距投稿21天可以收到，审稿人有3位，提出的审稿意见都比较有参考性，另外主编也会给予中肯的意见，编辑效率比较高，比较负责。从投文章到接收总共花了1.5个月左右，总体而言，该杂志效率高，审稿认真负责。文章具有创新是可以为接收的，建议大家依据期刊要求的参考文献风格进行撰写，语言凝练正确。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sat Oct 27 19:35:34 CST 2018, time=2018-10-27, status=1, ipAttribution=)]

2021-12-28 小动量

如果文章发表了未提供ORCIDID如何添加？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091886, encodeId=5787109188664, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091885, encodeId=6cea1091885c1, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861247, encodeId=119b86124e5d, content=审稿速度:2.0 经验分享：审核意见挺中肯的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Sun May 31 19:55:36 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854808, encodeId=47e485480833, content=审稿速度:3.0 经验分享：搜寻了yu chuck，好像此人只在他自己主编的这个期刊上发论文，而且基本上都不是一作。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Nov 07 10:56:55 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854807, encodeId=87fe85480e80, content=审稿速度:3.0 经验分享：yu chuck喜欢玩猫捉老鼠.先给你小修，然后再给你大修，最后给你拒绝。虽然你每次都认真改了，而且改的非常到位了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Nov 07 10:53:20 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853069, encodeId=ecd385306948, content=审稿速度:12.0 经验分享：yu chuck业内人品真不好说 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Fri Aug 09 10:00:37 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852280, encodeId=72f28522800a, content=24-feb-2019_submit 11-apr-2019_major revision 11-may-2019_a revision has been submitted (ibe-19-0060.r1) 09-jun-2019_minor revision_please provide institutional email address, not personal email address... 19-jun-2019_a revision has been submitted (ibe-19-0060.r2) 28-jun-2019_reject_at the moment, it seems the paper is written by a student who is not really an expert on indoor air quality... adm: yu, chuck , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893e5414041, createdName=ms8120435325541008, createdTime=Fri Jun 28 17:16:20 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851469, encodeId=b42d85146955, content=审稿速度:6.0 经验分享：审稿速度一般，4个月给初审结果，2个月以后给了小修结果，两周以后竟然在一个审稿人建议直接发表，另一个审稿人建议题目上添加“nunmerical study on”的情况下，给拒掉了，给拒掉了，给拒掉了......这是什么情况，让人太无语......除非必要，建议慎投. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Mon May 20 08:55:57 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847898, encodeId=80e484e898f2, content=期刊一审速度较快，大约20几天。三个审稿人，都给了比较专业的意见。主编认真负责，也提了一些中肯的修改意见。编辑也很细心，给予了文章的很多细节方面的修改。从投到接收大约一个半月左右，效率挺快的。总之，该期刊值得更多人的关注与投稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sat Oct 27 20:40:04 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847897, encodeId=c70a84e89730, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：该杂志审稿速度比较快，一审回复意见距投稿21天可以收到，审稿人有3位，提出的审稿意见都比较有参考性，另外主编也会给予中肯的意见，编辑效率比较高，比较负责。从投文章到接收总共花了1.5个月左右，总体而言，该杂志效率高，审稿认真负责。文章具有创新是可以为接收的，建议大家依据期刊要求的参考文献风格进行撰写，语言凝练正确。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sat Oct 27 19:35:34 CST 2018, time=2018-10-27, status=1, ipAttribution=)]

2021-12-27 ms6000000264964247

如何判断两种药物之间是协同作用还是相加作用？

62 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091886, encodeId=5787109188664, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091885, encodeId=6cea1091885c1, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861247, encodeId=119b86124e5d, content=审稿速度:2.0 经验分享：审核意见挺中肯的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Sun May 31 19:55:36 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854808, encodeId=47e485480833, content=审稿速度:3.0 经验分享：搜寻了yu chuck，好像此人只在他自己主编的这个期刊上发论文，而且基本上都不是一作。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Nov 07 10:56:55 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854807, encodeId=87fe85480e80, content=审稿速度:3.0 经验分享：yu chuck喜欢玩猫捉老鼠.先给你小修，然后再给你大修，最后给你拒绝。虽然你每次都认真改了，而且改的非常到位了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Nov 07 10:53:20 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853069, encodeId=ecd385306948, content=审稿速度:12.0 经验分享：yu chuck业内人品真不好说 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Fri Aug 09 10:00:37 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852280, encodeId=72f28522800a, content=24-feb-2019_submit 11-apr-2019_major revision 11-may-2019_a revision has been submitted (ibe-19-0060.r1) 09-jun-2019_minor revision_please provide institutional email address, not personal email address... 19-jun-2019_a revision has been submitted (ibe-19-0060.r2) 28-jun-2019_reject_at the moment, it seems the paper is written by a student who is not really an expert on indoor air quality... adm: yu, chuck , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893e5414041, createdName=ms8120435325541008, createdTime=Fri Jun 28 17:16:20 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851469, encodeId=b42d85146955, content=审稿速度:6.0 经验分享：审稿速度一般，4个月给初审结果，2个月以后给了小修结果，两周以后竟然在一个审稿人建议直接发表，另一个审稿人建议题目上添加“nunmerical study on”的情况下，给拒掉了，给拒掉了，给拒掉了......这是什么情况，让人太无语......除非必要，建议慎投. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Mon May 20 08:55:57 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847898, encodeId=80e484e898f2, content=期刊一审速度较快，大约20几天。三个审稿人，都给了比较专业的意见。主编认真负责，也提了一些中肯的修改意见。编辑也很细心，给予了文章的很多细节方面的修改。从投到接收大约一个半月左右，效率挺快的。总之，该期刊值得更多人的关注与投稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sat Oct 27 20:40:04 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847897, encodeId=c70a84e89730, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：该杂志审稿速度比较快，一审回复意见距投稿21天可以收到，审稿人有3位，提出的审稿意见都比较有参考性，另外主编也会给予中肯的意见，编辑效率比较高，比较负责。从投文章到接收总共花了1.5个月左右，总体而言，该杂志效率高，审稿认真负责。文章具有创新是可以为接收的，建议大家依据期刊要求的参考文献风格进行撰写，语言凝练正确。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sat Oct 27 19:35:34 CST 2018, time=2018-10-27, status=1, ipAttribution=)]

2020-05-31 ms9497043704145630

审稿速度:2.0
经验分享：审核意见挺中肯的

101 0

[GetPortalCommentsPageByObjectIdResponse(id=1091886, encodeId=5787109188664, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091885, encodeId=6cea1091885c1, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861247, encodeId=119b86124e5d, content=审稿速度:2.0 经验分享：审核意见挺中肯的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Sun May 31 19:55:36 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854808, encodeId=47e485480833, content=审稿速度:3.0 经验分享：搜寻了yu chuck，好像此人只在他自己主编的这个期刊上发论文，而且基本上都不是一作。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Nov 07 10:56:55 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854807, encodeId=87fe85480e80, content=审稿速度:3.0 经验分享：yu chuck喜欢玩猫捉老鼠.先给你小修，然后再给你大修，最后给你拒绝。虽然你每次都认真改了，而且改的非常到位了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Nov 07 10:53:20 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853069, encodeId=ecd385306948, content=审稿速度:12.0 经验分享：yu chuck业内人品真不好说 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Fri Aug 09 10:00:37 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852280, encodeId=72f28522800a, content=24-feb-2019_submit 11-apr-2019_major revision 11-may-2019_a revision has been submitted (ibe-19-0060.r1) 09-jun-2019_minor revision_please provide institutional email address, not personal email address... 19-jun-2019_a revision has been submitted (ibe-19-0060.r2) 28-jun-2019_reject_at the moment, it seems the paper is written by a student who is not really an expert on indoor air quality... adm: yu, chuck , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893e5414041, createdName=ms8120435325541008, createdTime=Fri Jun 28 17:16:20 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851469, encodeId=b42d85146955, content=审稿速度:6.0 经验分享：审稿速度一般，4个月给初审结果，2个月以后给了小修结果，两周以后竟然在一个审稿人建议直接发表，另一个审稿人建议题目上添加“nunmerical study on”的情况下，给拒掉了，给拒掉了，给拒掉了......这是什么情况，让人太无语......除非必要，建议慎投. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Mon May 20 08:55:57 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847898, encodeId=80e484e898f2, content=期刊一审速度较快，大约20几天。三个审稿人，都给了比较专业的意见。主编认真负责，也提了一些中肯的修改意见。编辑也很细心，给予了文章的很多细节方面的修改。从投到接收大约一个半月左右，效率挺快的。总之，该期刊值得更多人的关注与投稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sat Oct 27 20:40:04 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847897, encodeId=c70a84e89730, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：该杂志审稿速度比较快，一审回复意见距投稿21天可以收到，审稿人有3位，提出的审稿意见都比较有参考性，另外主编也会给予中肯的意见，编辑效率比较高，比较负责。从投文章到接收总共花了1.5个月左右，总体而言，该杂志效率高，审稿认真负责。文章具有创新是可以为接收的，建议大家依据期刊要求的参考文献风格进行撰写，语言凝练正确。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sat Oct 27 19:35:34 CST 2018, time=2018-10-27, status=1, ipAttribution=)]

2019-11-07 ms1700929302443684

审稿速度:3.0
经验分享：搜寻了yu chuck，好像此人只在他自己主编的这个期刊上发论文，而且基本上都不是一作。

81 0

[GetPortalCommentsPageByObjectIdResponse(id=1091886, encodeId=5787109188664, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091885, encodeId=6cea1091885c1, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861247, encodeId=119b86124e5d, content=审稿速度:2.0 经验分享：审核意见挺中肯的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Sun May 31 19:55:36 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854808, encodeId=47e485480833, content=审稿速度:3.0 经验分享：搜寻了yu chuck，好像此人只在他自己主编的这个期刊上发论文，而且基本上都不是一作。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Nov 07 10:56:55 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854807, encodeId=87fe85480e80, content=审稿速度:3.0 经验分享：yu chuck喜欢玩猫捉老鼠.先给你小修，然后再给你大修，最后给你拒绝。虽然你每次都认真改了，而且改的非常到位了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Nov 07 10:53:20 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853069, encodeId=ecd385306948, content=审稿速度:12.0 经验分享：yu chuck业内人品真不好说 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Fri Aug 09 10:00:37 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852280, encodeId=72f28522800a, content=24-feb-2019_submit 11-apr-2019_major revision 11-may-2019_a revision has been submitted (ibe-19-0060.r1) 09-jun-2019_minor revision_please provide institutional email address, not personal email address... 19-jun-2019_a revision has been submitted (ibe-19-0060.r2) 28-jun-2019_reject_at the moment, it seems the paper is written by a student who is not really an expert on indoor air quality... adm: yu, chuck , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893e5414041, createdName=ms8120435325541008, createdTime=Fri Jun 28 17:16:20 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851469, encodeId=b42d85146955, content=审稿速度:6.0 经验分享：审稿速度一般，4个月给初审结果，2个月以后给了小修结果，两周以后竟然在一个审稿人建议直接发表，另一个审稿人建议题目上添加“nunmerical study on”的情况下，给拒掉了，给拒掉了，给拒掉了......这是什么情况，让人太无语......除非必要，建议慎投. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Mon May 20 08:55:57 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847898, encodeId=80e484e898f2, content=期刊一审速度较快，大约20几天。三个审稿人，都给了比较专业的意见。主编认真负责，也提了一些中肯的修改意见。编辑也很细心，给予了文章的很多细节方面的修改。从投到接收大约一个半月左右，效率挺快的。总之，该期刊值得更多人的关注与投稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sat Oct 27 20:40:04 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847897, encodeId=c70a84e89730, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：该杂志审稿速度比较快，一审回复意见距投稿21天可以收到，审稿人有3位，提出的审稿意见都比较有参考性，另外主编也会给予中肯的意见，编辑效率比较高，比较负责。从投文章到接收总共花了1.5个月左右，总体而言，该杂志效率高，审稿认真负责。文章具有创新是可以为接收的，建议大家依据期刊要求的参考文献风格进行撰写，语言凝练正确。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sat Oct 27 19:35:34 CST 2018, time=2018-10-27, status=1, ipAttribution=)]

2019-11-07 ms6459520362745523

审稿速度:3.0
经验分享：yu chuck喜欢玩猫捉老鼠.先给你小修，然后再给你大修，最后给你拒绝。虽然你每次都认真改了，而且改的非常到位了。

92 0

[GetPortalCommentsPageByObjectIdResponse(id=1091886, encodeId=5787109188664, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091885, encodeId=6cea1091885c1, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861247, encodeId=119b86124e5d, content=审稿速度:2.0 经验分享：审核意见挺中肯的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Sun May 31 19:55:36 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854808, encodeId=47e485480833, content=审稿速度:3.0 经验分享：搜寻了yu chuck，好像此人只在他自己主编的这个期刊上发论文，而且基本上都不是一作。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Nov 07 10:56:55 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854807, encodeId=87fe85480e80, content=审稿速度:3.0 经验分享：yu chuck喜欢玩猫捉老鼠.先给你小修，然后再给你大修，最后给你拒绝。虽然你每次都认真改了，而且改的非常到位了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Nov 07 10:53:20 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853069, encodeId=ecd385306948, content=审稿速度:12.0 经验分享：yu chuck业内人品真不好说 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Fri Aug 09 10:00:37 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852280, encodeId=72f28522800a, content=24-feb-2019_submit 11-apr-2019_major revision 11-may-2019_a revision has been submitted (ibe-19-0060.r1) 09-jun-2019_minor revision_please provide institutional email address, not personal email address... 19-jun-2019_a revision has been submitted (ibe-19-0060.r2) 28-jun-2019_reject_at the moment, it seems the paper is written by a student who is not really an expert on indoor air quality... adm: yu, chuck , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893e5414041, createdName=ms8120435325541008, createdTime=Fri Jun 28 17:16:20 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851469, encodeId=b42d85146955, content=审稿速度:6.0 经验分享：审稿速度一般，4个月给初审结果，2个月以后给了小修结果，两周以后竟然在一个审稿人建议直接发表，另一个审稿人建议题目上添加“nunmerical study on”的情况下，给拒掉了，给拒掉了，给拒掉了......这是什么情况，让人太无语......除非必要，建议慎投. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Mon May 20 08:55:57 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847898, encodeId=80e484e898f2, content=期刊一审速度较快，大约20几天。三个审稿人，都给了比较专业的意见。主编认真负责，也提了一些中肯的修改意见。编辑也很细心，给予了文章的很多细节方面的修改。从投到接收大约一个半月左右，效率挺快的。总之，该期刊值得更多人的关注与投稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sat Oct 27 20:40:04 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847897, encodeId=c70a84e89730, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：该杂志审稿速度比较快，一审回复意见距投稿21天可以收到，审稿人有3位，提出的审稿意见都比较有参考性，另外主编也会给予中肯的意见，编辑效率比较高，比较负责。从投文章到接收总共花了1.5个月左右，总体而言，该杂志效率高，审稿认真负责。文章具有创新是可以为接收的，建议大家依据期刊要求的参考文献风格进行撰写，语言凝练正确。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sat Oct 27 19:35:34 CST 2018, time=2018-10-27, status=1, ipAttribution=)]

2019-08-09 ms8928334115937663

审稿速度:12.0
经验分享：yu chuck业内人品真不好说

110 0

[GetPortalCommentsPageByObjectIdResponse(id=1091886, encodeId=5787109188664, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091885, encodeId=6cea1091885c1, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861247, encodeId=119b86124e5d, content=审稿速度:2.0 经验分享：审核意见挺中肯的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Sun May 31 19:55:36 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854808, encodeId=47e485480833, content=审稿速度:3.0 经验分享：搜寻了yu chuck，好像此人只在他自己主编的这个期刊上发论文，而且基本上都不是一作。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Nov 07 10:56:55 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854807, encodeId=87fe85480e80, content=审稿速度:3.0 经验分享：yu chuck喜欢玩猫捉老鼠.先给你小修，然后再给你大修，最后给你拒绝。虽然你每次都认真改了，而且改的非常到位了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Nov 07 10:53:20 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853069, encodeId=ecd385306948, content=审稿速度:12.0 经验分享：yu chuck业内人品真不好说 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Fri Aug 09 10:00:37 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852280, encodeId=72f28522800a, content=24-feb-2019_submit 11-apr-2019_major revision 11-may-2019_a revision has been submitted (ibe-19-0060.r1) 09-jun-2019_minor revision_please provide institutional email address, not personal email address... 19-jun-2019_a revision has been submitted (ibe-19-0060.r2) 28-jun-2019_reject_at the moment, it seems the paper is written by a student who is not really an expert on indoor air quality... adm: yu, chuck , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893e5414041, createdName=ms8120435325541008, createdTime=Fri Jun 28 17:16:20 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851469, encodeId=b42d85146955, content=审稿速度:6.0 经验分享：审稿速度一般，4个月给初审结果，2个月以后给了小修结果，两周以后竟然在一个审稿人建议直接发表，另一个审稿人建议题目上添加“nunmerical study on”的情况下，给拒掉了，给拒掉了，给拒掉了......这是什么情况，让人太无语......除非必要，建议慎投. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Mon May 20 08:55:57 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847898, encodeId=80e484e898f2, content=期刊一审速度较快，大约20几天。三个审稿人，都给了比较专业的意见。主编认真负责，也提了一些中肯的修改意见。编辑也很细心，给予了文章的很多细节方面的修改。从投到接收大约一个半月左右，效率挺快的。总之，该期刊值得更多人的关注与投稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sat Oct 27 20:40:04 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847897, encodeId=c70a84e89730, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：该杂志审稿速度比较快，一审回复意见距投稿21天可以收到，审稿人有3位，提出的审稿意见都比较有参考性，另外主编也会给予中肯的意见，编辑效率比较高，比较负责。从投文章到接收总共花了1.5个月左右，总体而言，该杂志效率高，审稿认真负责。文章具有创新是可以为接收的，建议大家依据期刊要求的参考文献风格进行撰写，语言凝练正确。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sat Oct 27 19:35:34 CST 2018, time=2018-10-27, status=1, ipAttribution=)]

2019-06-28 ms8120435325541008

24-feb-2019_submit
11-apr-2019_major revision
11-may-2019_a revision has been submitted (ibe-19-0060.r1)
09-jun-2019_minor revision_please provide institutional email address, not personal email address...
19-jun-2019_a revision has been submitted (ibe-19-0060.r2)
28-jun-2019_reject_at the moment, it seems the paper is written by a student who is not really an expert on indoor air quality...
adm: yu, chuck

96 0

[GetPortalCommentsPageByObjectIdResponse(id=1091886, encodeId=5787109188664, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091885, encodeId=6cea1091885c1, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861247, encodeId=119b86124e5d, content=审稿速度:2.0 经验分享：审核意见挺中肯的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Sun May 31 19:55:36 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854808, encodeId=47e485480833, content=审稿速度:3.0 经验分享：搜寻了yu chuck，好像此人只在他自己主编的这个期刊上发论文，而且基本上都不是一作。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Nov 07 10:56:55 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854807, encodeId=87fe85480e80, content=审稿速度:3.0 经验分享：yu chuck喜欢玩猫捉老鼠.先给你小修，然后再给你大修，最后给你拒绝。虽然你每次都认真改了，而且改的非常到位了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Nov 07 10:53:20 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853069, encodeId=ecd385306948, content=审稿速度:12.0 经验分享：yu chuck业内人品真不好说 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Fri Aug 09 10:00:37 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852280, encodeId=72f28522800a, content=24-feb-2019_submit 11-apr-2019_major revision 11-may-2019_a revision has been submitted (ibe-19-0060.r1) 09-jun-2019_minor revision_please provide institutional email address, not personal email address... 19-jun-2019_a revision has been submitted (ibe-19-0060.r2) 28-jun-2019_reject_at the moment, it seems the paper is written by a student who is not really an expert on indoor air quality... adm: yu, chuck , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893e5414041, createdName=ms8120435325541008, createdTime=Fri Jun 28 17:16:20 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851469, encodeId=b42d85146955, content=审稿速度:6.0 经验分享：审稿速度一般，4个月给初审结果，2个月以后给了小修结果，两周以后竟然在一个审稿人建议直接发表，另一个审稿人建议题目上添加“nunmerical study on”的情况下，给拒掉了，给拒掉了，给拒掉了......这是什么情况，让人太无语......除非必要，建议慎投. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Mon May 20 08:55:57 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847898, encodeId=80e484e898f2, content=期刊一审速度较快，大约20几天。三个审稿人，都给了比较专业的意见。主编认真负责，也提了一些中肯的修改意见。编辑也很细心，给予了文章的很多细节方面的修改。从投到接收大约一个半月左右，效率挺快的。总之，该期刊值得更多人的关注与投稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sat Oct 27 20:40:04 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847897, encodeId=c70a84e89730, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：该杂志审稿速度比较快，一审回复意见距投稿21天可以收到，审稿人有3位，提出的审稿意见都比较有参考性，另外主编也会给予中肯的意见，编辑效率比较高，比较负责。从投文章到接收总共花了1.5个月左右，总体而言，该杂志效率高，审稿认真负责。文章具有创新是可以为接收的，建议大家依据期刊要求的参考文献风格进行撰写，语言凝练正确。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sat Oct 27 19:35:34 CST 2018, time=2018-10-27, status=1, ipAttribution=)]

2019-05-20 ms3908193925310106

审稿速度:6.0
经验分享：审稿速度一般，4个月给初审结果，2个月以后给了小修结果，两周以后竟然在一个审稿人建议直接发表，另一个审稿人建议题目上添加“nunmerical study on”的情况下，给拒掉了，给拒掉了，给拒掉了......这是什么情况，让人太无语......除非必要，建议慎投.

100 0

[GetPortalCommentsPageByObjectIdResponse(id=1091886, encodeId=5787109188664, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091885, encodeId=6cea1091885c1, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861247, encodeId=119b86124e5d, content=审稿速度:2.0 经验分享：审核意见挺中肯的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Sun May 31 19:55:36 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854808, encodeId=47e485480833, content=审稿速度:3.0 经验分享：搜寻了yu chuck，好像此人只在他自己主编的这个期刊上发论文，而且基本上都不是一作。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Nov 07 10:56:55 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854807, encodeId=87fe85480e80, content=审稿速度:3.0 经验分享：yu chuck喜欢玩猫捉老鼠.先给你小修，然后再给你大修，最后给你拒绝。虽然你每次都认真改了，而且改的非常到位了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Nov 07 10:53:20 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853069, encodeId=ecd385306948, content=审稿速度:12.0 经验分享：yu chuck业内人品真不好说 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Fri Aug 09 10:00:37 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852280, encodeId=72f28522800a, content=24-feb-2019_submit 11-apr-2019_major revision 11-may-2019_a revision has been submitted (ibe-19-0060.r1) 09-jun-2019_minor revision_please provide institutional email address, not personal email address... 19-jun-2019_a revision has been submitted (ibe-19-0060.r2) 28-jun-2019_reject_at the moment, it seems the paper is written by a student who is not really an expert on indoor air quality... adm: yu, chuck , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893e5414041, createdName=ms8120435325541008, createdTime=Fri Jun 28 17:16:20 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851469, encodeId=b42d85146955, content=审稿速度:6.0 经验分享：审稿速度一般，4个月给初审结果，2个月以后给了小修结果，两周以后竟然在一个审稿人建议直接发表，另一个审稿人建议题目上添加“nunmerical study on”的情况下，给拒掉了，给拒掉了，给拒掉了......这是什么情况，让人太无语......除非必要，建议慎投. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Mon May 20 08:55:57 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847898, encodeId=80e484e898f2, content=期刊一审速度较快，大约20几天。三个审稿人，都给了比较专业的意见。主编认真负责，也提了一些中肯的修改意见。编辑也很细心，给予了文章的很多细节方面的修改。从投到接收大约一个半月左右，效率挺快的。总之，该期刊值得更多人的关注与投稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sat Oct 27 20:40:04 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847897, encodeId=c70a84e89730, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：该杂志审稿速度比较快，一审回复意见距投稿21天可以收到，审稿人有3位，提出的审稿意见都比较有参考性，另外主编也会给予中肯的意见，编辑效率比较高，比较负责。从投文章到接收总共花了1.5个月左右，总体而言，该杂志效率高，审稿认真负责。文章具有创新是可以为接收的，建议大家依据期刊要求的参考文献风格进行撰写，语言凝练正确。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sat Oct 27 19:35:34 CST 2018, time=2018-10-27, status=1, ipAttribution=)]

2018-10-27 ms1582630781068122

期刊一审速度较快，大约20几天。三个审稿人，都给了比较专业的意见。主编认真负责，也提了一些中肯的修改意见。编辑也很细心，给予了文章的很多细节方面的修改。从投到接收大约一个半月左右，效率挺快的。总之，该期刊值得更多人的关注与投稿。

83 0

[GetPortalCommentsPageByObjectIdResponse(id=1091886, encodeId=5787109188664, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091885, encodeId=6cea1091885c1, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861247, encodeId=119b86124e5d, content=审稿速度:2.0 经验分享：审核意见挺中肯的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Sun May 31 19:55:36 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854808, encodeId=47e485480833, content=审稿速度:3.0 经验分享：搜寻了yu chuck，好像此人只在他自己主编的这个期刊上发论文，而且基本上都不是一作。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Thu Nov 07 10:56:55 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854807, encodeId=87fe85480e80, content=审稿速度:3.0 经验分享：yu chuck喜欢玩猫捉老鼠.先给你小修，然后再给你大修，最后给你拒绝。虽然你每次都认真改了，而且改的非常到位了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Nov 07 10:53:20 CST 2019, time=2019-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853069, encodeId=ecd385306948, content=审稿速度:12.0 经验分享：yu chuck业内人品真不好说 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Fri Aug 09 10:00:37 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852280, encodeId=72f28522800a, content=24-feb-2019_submit 11-apr-2019_major revision 11-may-2019_a revision has been submitted (ibe-19-0060.r1) 09-jun-2019_minor revision_please provide institutional email address, not personal email address... 19-jun-2019_a revision has been submitted (ibe-19-0060.r2) 28-jun-2019_reject_at the moment, it seems the paper is written by a student who is not really an expert on indoor air quality... adm: yu, chuck , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893e5414041, createdName=ms8120435325541008, createdTime=Fri Jun 28 17:16:20 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851469, encodeId=b42d85146955, content=审稿速度:6.0 经验分享：审稿速度一般，4个月给初审结果，2个月以后给了小修结果，两周以后竟然在一个审稿人建议直接发表，另一个审稿人建议题目上添加“nunmerical study on”的情况下，给拒掉了，给拒掉了，给拒掉了......这是什么情况，让人太无语......除非必要，建议慎投. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Mon May 20 08:55:57 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847898, encodeId=80e484e898f2, content=期刊一审速度较快，大约20几天。三个审稿人，都给了比较专业的意见。主编认真负责，也提了一些中肯的修改意见。编辑也很细心，给予了文章的很多细节方面的修改。从投到接收大约一个半月左右，效率挺快的。总之，该期刊值得更多人的关注与投稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sat Oct 27 20:40:04 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847897, encodeId=c70a84e89730, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：该杂志审稿速度比较快，一审回复意见距投稿21天可以收到，审稿人有3位，提出的审稿意见都比较有参考性，另外主编也会给予中肯的意见，编辑效率比较高，比较负责。从投文章到接收总共花了1.5个月左右，总体而言，该杂志效率高，审稿认真负责。文章具有创新是可以为接收的，建议大家依据期刊要求的参考文献风格进行撰写，语言凝练正确。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sat Oct 27 19:35:34 CST 2018, time=2018-10-27, status=1, ipAttribution=)]

2018-10-27 ms8341280369405896

审稿速度:2.0 | 投稿命中率:25.0
经验分享：该杂志审稿速度比较快，一审回复意见距投稿21天可以收到，审稿人有3位，提出的审稿意见都比较有参考性，另外主编也会给予中肯的意见，编辑效率比较高，比较负责。从投文章到接收总共花了1.5个月左右，总体而言，该杂志效率高，审稿认真负责。文章具有创新是可以为接收的，建议大家依据期刊要求的参考文献风格进行撰写，语言凝练正确。

99 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务